Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence.
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
pubmed:
3
6
2020
medline:
3
2
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
Cryptococcus neoformans is an opportunistic yeast that is present worldwide and interacts with various organisms. In humans, it is responsible for cryptococcosis, a deadly invasive fungal infection that represents around 220,000 cases per year worldwide. Starting from the natural history of the disease in humans, there is accumulating evidence on the capacity of this organism to enter dormancy. In response to the harsh host environment, the yeast is able to adapt dramatically and escape the vigilance of the host's immune cells to survive. Indeed, the yeast exposed to the host takes on pleiotropic phenotypes, enabling the generation of populations in heterogeneous states, including dormancy, to eventually survive at low metabolic cost and revive in favorable conditions. The concept of dormancy has been validated in C. neoformans from both epidemiological and genotyping data, and more recently from the biological point of view with the characterization of dormancy through the description of viable but nonculturable cells.
Identifiants
pubmed: 32484459
pii: 136223
doi: 10.1172/JCI136223
pmc: PMC7324190
doi:
pii:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3353-3360Références
Microb Ecol. 1982 Dec;8(4):313-23
pubmed: 24226049
Front Microbiol. 2017 Apr 04;8:580
pubmed: 28421064
Med Mycol. 2003 Jun;41(3):177-88
pubmed: 12964709
Infect Immun. 2008 Oct;76(10):4764-71
pubmed: 18678670
Lung. 2012 Jun;190(3):339-46
pubmed: 22246551
Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):751-6
pubmed: 18831914
Antimicrob Agents Chemother. 2010 Jan;54(1):39-44
pubmed: 19841146
mBio. 2010 May 18;1(1):
pubmed: 20689742
Tubercle. 1951 Nov;32(11):232-7
pubmed: 14893467
N Engl J Med. 2005 Mar 24;352(12):1271-2
pubmed: 15788512
AIDS. 2002 May 3;16(7):1031-8
pubmed: 11953469
Am J Clin Pathol. 1976 Jan;65(1):83-92
pubmed: 1246992
BMJ Case Rep. 2013 Sep 06;2013:
pubmed: 24014328
Medicine (Baltimore). 1996 May;75(3):142-56
pubmed: 8965683
Infect Immun. 1999 Feb;67(2):885-90
pubmed: 9916104
PLoS One. 2016 Apr 07;11(4):e0153356
pubmed: 27054608
Microbiology. 2003 Aug;149(Pt 8):2147-2154
pubmed: 12904554
Pediatr Infect Dis J. 2007 Jun;26(6):549-51
pubmed: 17529880
J Infect Dis. 1972 Apr;125(4):367-76
pubmed: 4553080
J Clin Invest. 2010 May;120(5):1683-93
pubmed: 20424328
Med Mycol. 2019 Feb 1;57(2):133-150
pubmed: 30329097
Infect Immun. 1997 Nov;65(11):4564-71
pubmed: 9353034
J Med Vet Mycol. 1992;30(5):395-7
pubmed: 1469541
Pediatrics. 2001 May;107(5):E66
pubmed: 11331716
N Engl J Med. 1993 May 6;328(18):1354-5
pubmed: 8469264
Nat Rev Microbiol. 2007 Jan;5(1):48-56
pubmed: 17143318
Biochem Soc Trans. 2014 Aug;42(4):1112-7
pubmed: 25110011
Front Microbiol. 2018 Mar 13;9:409
pubmed: 29593675
J Allergy. 1968 May;41(5):297-301
pubmed: 4870739
Science. 2018 Jun 22;360(6395):
pubmed: 29930109
Trop Med Int Health. 2007 Aug;12(8):929-35
pubmed: 17697087
Zentralbl Bakteriol Mikrobiol Hyg B. 1984 May;179(2):179-86
pubmed: 6377755
Respir Care. 2004 Jun;49(6):606-8
pubmed: 15165294
Antimicrob Agents Chemother. 2006 Nov;50(11):3839-46
pubmed: 16923951
J Exp Med. 1992 Jun 1;175(6):1685-95
pubmed: 1588288
Front Microbiol. 2016 Dec 27;7:2134
pubmed: 28082974
Genetics. 2017 Sep;207(1):327-346
pubmed: 28679543
Mem Inst Oswaldo Cruz. 2018;113(7):e180050
pubmed: 29742199
Curr Biol. 2006 Nov 7;16(21):2161-5
pubmed: 17084702
PLoS Med. 2007 Feb;4(2):e21
pubmed: 17284154
Infect Immun. 2000 Jul;68(7):4225-37
pubmed: 10858240
PLoS Pathog. 2019 Jul 29;15(7):e1007945
pubmed: 31356623
mBio. 2011 Aug 09;2(4):
pubmed: 21828219
Clin Infect Dis. 2003 Feb 1;36(3):337-47
pubmed: 12539076
Clin Infect Dis. 2011 Feb 15;52(4):e94-8
pubmed: 21220771
FEMS Microbiol Rev. 2012 May;36(3):514-32
pubmed: 22320122
Am J Clin Pathol. 1985 Nov;84(5):598-602
pubmed: 4061382
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):189-94
pubmed: 23542636
Mol Cell. 2017 Sep 21;67(6):936-946.e5
pubmed: 28918901
J Infect Dis. 2011 Jun 1;203(11):1686-91
pubmed: 21592999
FEMS Yeast Res. 2006 Jun;6(4):599-607
pubmed: 16696655
Infect Immun. 2009 Jan;77(1):120-7
pubmed: 18936186
Microbiology. 2010 Jan;156(Pt 1):81-7
pubmed: 19797356
Infect Immun. 2009 Aug;77(8):3491-500
pubmed: 19451235
Oxf Med Case Reports. 2018 Oct 17;2018(11):omy083
pubmed: 30364356
J Clin Diagn Res. 2014 Feb;8(2):137-8
pubmed: 24701506
Clin Infect Dis. 2010 Feb 1;50(3):291-322
pubmed: 20047480
Sci Rep. 2019 May 16;9(1):7493
pubmed: 31097746
J Crohns Colitis. 2013 Feb;7(1):e11-4
pubmed: 22647638
Mol Ecol. 2000 Oct;9(10):1471-81
pubmed: 11050543
J Bacteriol. 1980 Sep;143(3):1384-94
pubmed: 6997270
Transplantation. 1971 Apr;11(4):428-9
pubmed: 4934356
mBio. 2011 Aug 09;2(4):
pubmed: 21828220
FEMS Microbiol Lett. 1995 Jun 15;129(2-3):231-5
pubmed: 7607405
Microbiol Mol Biol Rev. 2004 Jun;68(2):187-206
pubmed: 15187181
Mycoses. 1989 Jan;32(1):7-13
pubmed: 2664505
J Bacteriol. 1951 Dec;62(6):685-90
pubmed: 14907620
mBio. 2018 Jul 31;9(4):
pubmed: 30065087
Med Mycol. 1998 Oct;36(5):305-11
pubmed: 10075500
Clin Infect Dis. 2020 Jan 2;70(2):252-261
pubmed: 30855688
mBio. 2011 Sep 27;2(5):
pubmed: 21954307
J Bacteriol. 2014 Apr;196(7):1297-305
pubmed: 24488313
Infect Control Hosp Epidemiol. 1993 Dec;14(12):719-22
pubmed: 8132998
Appl Environ Microbiol. 2002 Oct;68(10):4884-93
pubmed: 12324335
J Clin Invest. 2014 May;124(5):2000-8
pubmed: 24743149
BMC Immunol. 2007 Aug 16;8:16
pubmed: 17705844
J Clin Exp Hematop. 2017 Jul 5;57(1):26-30
pubmed: 28592745
Mol Cell Biol. 1994 Jul;14(7):4912-9
pubmed: 8007987
J Appl Microbiol. 2005;98(4):862-71
pubmed: 15752332
FEMS Microbiol Rev. 2008 Jan;32(1):56-106
pubmed: 18173393
Curr Opin Microbiol. 2003 Aug;6(4):332-7
pubmed: 12941400
J Clin Invest. 2001 Dec;108(11):1639-48
pubmed: 11733559
PLoS One. 2015 Feb 17;10(2):e0115866
pubmed: 25688971
mBio. 2014 Feb 04;5(1):e01087-13
pubmed: 24496797
Eukaryot Cell. 2005 Aug;4(8):1420-33
pubmed: 16087747
Ultrastruct Pathol. 2011 Feb;35(1):19-25
pubmed: 21214404
PLoS Pathog. 2010 Aug 12;6(8):e1001041
pubmed: 20714349
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12980-5
pubmed: 19651610
Ann Intern Med. 2000 Feb 1;132(3):205-8
pubmed: 10651601
N Engl J Med. 2018 Mar 15;378(11):1004-1017
pubmed: 29539274
Emerg Infect Dis. 2010 Feb;16(2):251-7
pubmed: 20113555
Am Rev Respir Dis. 1968 Apr;97(4):637-43
pubmed: 5644326
Am J Pathol. 1980 Oct;101(1):177-94
pubmed: 7004196
Emerg Infect Dis. 2014 Jul;20(7):1149-55
pubmed: 24960557
Mol Biol Cell. 2011 Apr;22(7):988-98
pubmed: 21289090
Case Rep Pediatr. 2013;2013:563081
pubmed: 23862091
PLoS One. 2013 Oct 29;8(10):e77600
pubmed: 24204887
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415
J Immunol. 2019 May 1;202(9):2661-2670
pubmed: 30877168
J Clin Microbiol. 1999 Oct;37(10):3204-9
pubmed: 10488178
Cell Host Microbe. 2013 Jun 12;13(6):643-51
pubmed: 23768489
PLoS Pathog. 2011 Nov;7(11):e1002364
pubmed: 22114551
Eukaryot Cell. 2003 Dec;2(6):1336-49
pubmed: 14665467
mBio. 2013 Dec 31;5(1):e00986-13
pubmed: 24381301
Clin Vaccine Immunol. 2007 Dec;14(12):1550-4
pubmed: 17959819
Eukaryot Cell. 2013 May;12(5):761-74
pubmed: 23524994
J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):555-9
pubmed: 17577124
Yeast. 1998 Dec;14(16):1511-27
pubmed: 9885153
J Clin Microbiol. 1994 Apr;32(4):1088-91
pubmed: 8027319
Microbes Infect. 2016 Jan;18(1):57-67
pubmed: 26369713
Nat Rev Microbiol. 2006 Feb;4(2):113-20
pubmed: 16415927
Mol Microbiol. 2008 Sep;69(6):1456-75
pubmed: 18673460
Cell Microbiol. 2012 Dec;14(12):1819-27
pubmed: 22966777
AIDS. 2009 Feb 20;23(4):525-30
pubmed: 19182676
Infect Immun. 2015 Nov;83(11):4194-203
pubmed: 26283335
Med Mycol. 2010 Nov;48(7):932-41
pubmed: 20302549
N Engl J Med. 2013 Apr 4;368(14):1291-1302
pubmed: 23550668
mBio. 2015 Mar 31;6(2):
pubmed: 25827423